Controversial issues in the neoadjuvant treatment of triple-negative breast cancer

por Fitzpatrick, Amanda, Tutt, Andrew
Publicado 2019

Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence?

por Turner, Nicholas C, Tutt, Andrew NJ
Publicado 2012

Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers

por Watkins, Johnathan A, Irshad, Sheeba, Grigoriadis, Anita, Tutt, Andrew NJ
Publicado 2014

Comparative Membranome Expression Analysis in Primary Tumors and Derived Cell Lines

por Uva, Paolo, Lahm, Armin, Sbardellati, Andrea, Grigoriadis, Anita, Tutt, Andrew, de Rinaldis, Emanuele
Publicado 2010

LMD-18. Detection and serial monitoring of CSF ctDNA in breast cancer leptomeningeal disease (BCLM)

por Fitzpatrick, Amanda, Iravani, Marjan, Okines, Alicia, Mills, Adam, Harries, Mark, Tutt, Andrew, Isacke, Clare
Publicado 2021

Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment

por Flores-Borja, Fabian, Irshad, Sheeba, Gordon, Peter, Wong, Felix, Sheriff, Ibrahim, Tutt, Andrew, Ng, Tony
Publicado 2016

Opinion: PARP inhibitors in cancer—what do we still need to know?

por Wicks, Andrew J., Krastev, Dragomir B., Pettitt, Stephen J., Tutt, Andrew N. J., Lord, Christopher J.
Publicado 2022

Molecular characterisation of cell line models for triple-negative breast cancers

por Grigoriadis, Anita, Mackay, Alan, Noel, Elodie, Wu, Pei Jun, Natrajan, Rachel, Frankum, Jessica, Reis-Filho, Jorge S, Tutt, Andrew
Publicado 2012

Managing non-proportionality of hazards (PH) within TNT: a randomised phase III trial of carboplatin compared to docetaxel for patients with metastatic or recurrent locally advance...

por Tovey, Holly, Bliss, Judith, Tutt, Andrew, Morden, James, Jarman, Katy, Martin, Sue, Kernaghan, Sarah, Toms, Christy, Kilburn, Lucy
Publicado 2015

Are triple-negative tumours and basal-like breast cancer synonymous?

por Rakha, Emad A, Tan, David SP, Foulkes, William D, Ellis, Ian O, Tutt, Andrew, Nielsen, Torsten O, Reis-Filho, Jorge S
Publicado 2007

DART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inference

por Jiao, Yan, Lawler, Katherine, Patel, Gargi S, Purushotham, Arnie, Jones, Annette F, Grigoriadis, Anita, Tutt, Andrew, Ng, Tony, Teschendorff, Andrew E
Publicado 2011

Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial

por Yamauchi, Hideko, Toi, Masakazu, Takayama, Shin, Nakamura, Seigo, Takano, Toshimi, Cui, Karen, Campbell, Christine, De Vos, Liesbet, Geyer, Charles, Tutt, Andrew
Publicado 2023

Correction: Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial

por Yamauchi, Hideko, Toi, Masakazu, Takayama, Shin, Nakamura, Seigo, Takano, Toshimi, Cui, Karen, Campbell, Christine, De Vos, Liesbet, Geyer, Charles, Tutt, Andrew
Publicado 2023

Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B

por Akre, Monica K., Starrett, Gabriel J., Quist, Jelmar S., Temiz, Nuri A., Carpenter, Michael A., Tutt, Andrew N. J., Grigoriadis, Anita, Harris, Reuben S.
Publicado 2016

Genomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotype

por Fitzpatrick, Amanda, Iravani, Marjan, Mills, Adam, Vicente, David, Alaguthurai, Thanussuyah, Roxanis, Ioannis, Turner, Nicholas C., Haider, Syed, Tutt, Andrew N. J., Isacke, Clare M.
Publicado 2023

Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients’ survival

por Gracio, Filipe, Burford, Brian, Gazinska, Patrycja, Mera, Anca, Mohd Noor, Aisyah, Marra, Pierfrancesco, Gillett, Cheryl, Grigoriadis, Anita, Pinder, Sarah, Tutt, Andrew, de Rinaldis, Emanuele
Publicado 2017

An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk

por Yau, Christina, Sninsky, John, Kwok, Shirley, Wang, Alice, Degnim, Amy, Ingle, James N, Gillett, Cheryl, Tutt, Andrew, Waldman, Fred, Moore, Dan, Esserman, Laura, Benz, Christopher C
Publicado 2013

Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node‐positive breast cancers

por Grigoriadis, Anita, Gazinska, Patrycja, Pai, Trupti, Irhsad, Sheeba, Wu, Yin, Millis, Rosemary, Naidoo, Kalnisha, Owen, Julie, Gillett, Cheryl E, Tutt, Andrew, Coolen, Anthonius CC, Pinder, Sarah E
Publicado 2018

Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control

por de Rinaldis, Emanuele, Gazinska, Patrycja, Mera, Anca, Modrusan, Zora, Fedorowicz, Grazyna M, Burford, Brian, Gillett, Cheryl, Marra, Pierfrancesco, Grigoriadis, Anita, Dornan, David, Holmberg, Lars, Pinder, Sarah, Tutt, Andrew
Publicado 2013

Mouse mammary stem cells express prognostic markers for triple-negative breast cancer

por Soady, Kelly J, Kendrick, Howard, Gao, Qiong, Tutt, Andrew, Zvelebil, Marketa, Ordonez, Liliana D, Quist, Jelmar, Tan, David Wei-Min, Isacke, Clare M, Grigoriadis, Anita, Smalley, Matthew J
Publicado 2015